These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1518 related items for PubMed ID: 19273703

  • 1. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M.
    J Clin Oncol; 2009 Apr 20; 27(12):2030-7. PubMed ID: 19273703
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.
    Solomides CC, Evans BJ, Navenot JM, Vadigepalli R, Peiper SC, Wang ZX.
    Acta Cytol; 2012 Apr 20; 56(6):645-54. PubMed ID: 23207443
    [Abstract] [Full Text] [Related]

  • 3. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y.
    Biomed Pharmacother; 2010 Jul 20; 64(6):399-408. PubMed ID: 20363096
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.
    Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG.
    Cancer Res; 2009 Jul 15; 69(14):5776-83. PubMed ID: 19584273
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
    Patnaik SK, Kannisto E, Knudsen S, Yendamuri S.
    Cancer Res; 2010 Jan 01; 70(1):36-45. PubMed ID: 20028859
    [Abstract] [Full Text] [Related]

  • 6. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.
    Hamamoto J, Soejima K, Yoda S, Naoki K, Nakayama S, Satomi R, Terai H, Ikemura S, Sato T, Yasuda H, Hayashi Y, Sakamoto M, Takebayashi T, Betsuyaku T.
    Mol Med Rep; 2013 Aug 01; 8(2):456-62. PubMed ID: 23759980
    [Abstract] [Full Text] [Related]

  • 7. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
    Cho WC, Chow AS, Au JS.
    Eur J Cancer; 2009 Aug 01; 45(12):2197-206. PubMed ID: 19493678
    [Abstract] [Full Text] [Related]

  • 8. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
    Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, Westra WH.
    Clin Cancer Res; 2010 Jan 15; 16(2):610-9. PubMed ID: 20068099
    [Abstract] [Full Text] [Related]

  • 9. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
    Kim B, Lee HJ, Choi HY, Shin Y, Nam S, Seo G, Son DS, Jo J, Kim J, Lee J, Kim J, Kim K, Lee S.
    Cancer Res; 2007 Aug 01; 67(15):7431-8. PubMed ID: 17671213
    [Abstract] [Full Text] [Related]

  • 10. Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens.
    Huang W, Hu J, Yang DW, Fan XT, Jin Y, Hou YY, Wang JP, Yuan YF, Tan YS, Zhu XZ, Bai CX, Wu Y, Zhu HG, Lu SH.
    Am J Respir Crit Care Med; 2012 Dec 01; 186(11):1160-7. PubMed ID: 23043084
    [Abstract] [Full Text] [Related]

  • 11. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.
    Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, Shen H.
    J Clin Oncol; 2010 Apr 01; 28(10):1721-6. PubMed ID: 20194856
    [Abstract] [Full Text] [Related]

  • 12. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.
    Hofmann HS, Bartling B, Simm A, Murray R, Aziz N, Hansen G, Silber RE, Burdach S.
    Oncol Rep; 2006 Sep 01; 16(3):587-95. PubMed ID: 16865260
    [Abstract] [Full Text] [Related]

  • 13. HMGA2 overexpression in non-small cell lung cancer.
    Meyer B, Loeschke S, Schultze A, Weigel T, Sandkamp M, Goldmann T, Vollmer E, Bullerdiek J.
    Mol Carcinog; 2007 Jul 01; 46(7):503-11. PubMed ID: 17477356
    [Abstract] [Full Text] [Related]

  • 14. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R, Vallbohmer D, Müller-Tidow C, Higashi H, Bollschweiler E, Warnecke-Eberz U, Brabender J, Baldus SE, Xi H, Berdel WE, Serve H, Hoelscher AH, Schneider PM.
    Anticancer Res; 2009 Apr 01; 29(4):1157-62. PubMed ID: 19414359
    [Abstract] [Full Text] [Related]

  • 15. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.
    Wikman H, Seppänen JK, Sarhadi VK, Kettunen E, Salmenkivi K, Kuosma E, Vainio-Siukola K, Nagy B, Karjalainen A, Sioris T, Salo J, Hollmén J, Knuutila S, Anttila S.
    J Pathol; 2004 May 01; 203(1):584-93. PubMed ID: 15095482
    [Abstract] [Full Text] [Related]

  • 16. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M, Geraci M, Gao B, Powell RL, Hirsch FR, Johnson G, Lapadat R, Gabrielson E, Bremnes R, Bunn PA, Franklin WA.
    Cancer Res; 2002 Jul 15; 62(14):3971-9. PubMed ID: 12124329
    [Abstract] [Full Text] [Related]

  • 17. Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase.
    Ceppi P, Volante M, Saviozzi S, Rapa I, Novello S, Cambieri A, Lo Iacono M, Cappia S, Papotti M, Scagliotti GV.
    Cancer; 2006 Oct 01; 107(7):1589-96. PubMed ID: 16955506
    [Abstract] [Full Text] [Related]

  • 18. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S, Fields CR, Su N, Pan YX, Robertson KD.
    Oncogene; 2007 Apr 19; 26(18):2621-34. PubMed ID: 17043644
    [Abstract] [Full Text] [Related]

  • 19. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis.
    Tan X, Qin W, Zhang L, Hang J, Li B, Zhang C, Wan J, Zhou F, Shao K, Sun Y, Wu J, Zhang X, Qiu B, Li N, Shi S, Feng X, Zhao S, Wang Z, Zhao X, Chen Z, Mitchelson K, Cheng J, Guo Y, He J.
    Clin Cancer Res; 2011 Nov 01; 17(21):6802-11. PubMed ID: 21890451
    [Abstract] [Full Text] [Related]

  • 20. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ.
    J Thorac Oncol; 2011 Mar 01; 6(3):482-8. PubMed ID: 21258252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.